Adapx raises $2 million
Adapx, which makes software that works in conjunction with digital pen technologies, has raised an additional $2 million that it will use to expand its Capturx online service.
ActoGeniX, a Dutch drug company whose lead candidate is focused on inflammatory bowel disease, has raised €13.5 million in second-round funding.